Radiosensitivity Enhancement using Triptorelin Conjugated Bismuth Sulfide Nanoparticles (Bi<sub>2</sub>S<sub>3</sub>@BSA) in Radiotherapy for Breast Cancer Cells

<div>Schematic illustration of targeted Bi<sub>2</sub>S<sub>3</sub>@BSA NPs as a targeted radiosensitizer for radiotherapy.</div>

Journal of Nanomaterials

fig1

Figure 1

Figure 1: Radiosensitivity Enhancement using Triptorelin Conjugated Bismuth Sulfide Nanoparticles (Bi<sub>2</sub>S<sub>3</sub>@BSA) in Radiotherapy for Breast Cancer Cells 

Figure 1 | Radiosensitivity Enhancement using Triptorelin Conjugated Bismuth Sulfide Nanoparticles (Bi2S3@BSA) in Radiotherapy for Breast Cancer Cells 